28 Polen Capital Novo Nordisk Trades
Polen Capital acquired 179k Novo Nordisk shares worth $10M. That's 0.03% of their equity portfolio (47th largest holding). The first Novo Nordisk trade was made in Q2 2013. Since then Polen Capital bought shares eighteen more times and sold shares on nine occasions. The investor's estimated purchase price is $29.3M, resulting in a loss of 66%.
News about Novo Nordisk - ADR and Polen Capital
Novo Nordisk A/S (NVO) Q2 2025 Earnings Call Transcript
Novo Nordisk A/S (NVO) Q2 2025 Earnings Conference Call August 6, 2025 7:00 AM ET Company Participants David S. Moore - Executive VP of US Operations & Membe...
Novo Nordisk needs something new, outside of weigh-loss drugs, says BMO's Seigerman
Evan Seigerman, BMO Capital Markets, joins 'Fast Money' to talk to Nono Nordisk sinking on guidance cut.
BMO's Evan David Seigerman: Novo Nordisk CEO departure reflects disparity with Eli Lilly
Evan David Seigerman, BMO Capital Markets head of healthcare research, joins CNBC's 'Money Movers' to discuss reactions to the departure of Novo Nordisk's CE...
Novo Nordisk A/S (NVO) Q2 2024 Earnings Call Transcript
Novo Nordisk A/S (NVO) Q2 2024 Earnings Conference Call August 7, 2024 7:00 AM ET Company Participants Jacob Martin Wiborg Rode - Head of Investor Relations ...